Drugs & TargetsFree Yisheng’s biological product for pancreatic cancer gets Orphan Drug Designation March 02, 2018Vol.44 No.09
Drugs & TargetsFree FDA expands approval of Imfinzi to reduce the risk of NSCLC progressing February 23, 2018Vol.44 No.08
Drugs & Targets FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint February 16, 2018Vol.44 No.07
Drugs & Targets BMS, Nektar form collaboration for CD122-biased agonist February 16, 2018Vol.44 No.07
Drugs & Targets Tivozanib gets NICE nod for first-line treatment of advanced RCC February 16, 2018Vol.44 No.07
Drugs & Targets FDA approves abiraterone acetate in combination with prednisone for high-risk metastatic castration-sensitive prostate cancer February 09, 2018Vol.44 No.06
Drugs & Targets Foundation Medicine and EORTC collaborate comprehensive genomic profiling February 09, 2018Vol.44 No.06
Drugs & Targets Abbott PathVysion HER-2 DNA Probe assay to be used in ANGLE study February 09, 2018Vol.44 No.06
Drugs & Targets FDA approves lutetium Lu 177 dotatate for treatment of GEP-NETS February 02, 2018Vol.44 No.05
